CANNON LAB

Periodic Paralysis Association 2021

  • Repurposing a Drug Effective for Preventing Attacks of HypoPP
  • A "Benign" SCN4A Variant that cal be Problematic with a CLCN1 Defect
  • Gene Editing (CRISPR) for Periodic Paralysis

Contributed by Stephen Caldwell Cannon